OTC Drug Plaintiff Fit To Be Fryed In New York


Just when we’re disgruntledly packing away our “Fry Mumia” buttons for the last time (guilty as sin, that one was), we get word from New York that the plaintiff in one of Dechert’s Tylenol cases lost a Frye-based appeal. Unfortunately, because Ratner v. McNeil-PPC, Inc., ___ N.Y.S.2d ___, 2011 WL 5865657 (N.Y.A.D. Nov. 22, 2011), is one of our cases, we can’t supersize this post. But we can give you an outline of what happened.

First, Ratner is an example of the philosophy behind this blog – that a defense win anywhere helps defendants everywhere. A few years ago we (well, Bexis) participated in an amicus brief filed by the Product Liability Advisory Council, Inc. (“PLAC”) in a case called Parker v. Mobil Oil. That appeal turned out well, producing an excellent Frye-based expert opinion – Parker v Mobil Oil Corp., 857 N.E.2d 1114 (N.Y. 2006). Parker, in turn became the foundation for the recent win in Ratner.

So what happened?

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.